Nutritional supplement for treatment of ocular diseases
US7887847B2 · kind B2 · utility
Inventor
Key dates
| Filing date | May 5, 2005 |
| Grant date | Feb 15, 2011 |
| Priority date | — |
| Expiry date | Mar 27, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A nutritional supplement composition that promotes visual health and reduces or reverses visual acuity loss by a reduced Vitamin E content from standard supplements with the addition of taurine, omega-3 fatty acids, and non proform Vitamin A carotenoids including lutein and zeaxanthin. The essential ingredients of the nutritional or dietary supplements are Vitamin C, no more than 300 IUs of Vitamin E, Vitamin A at least a portion of which is provided in the form of a proform Vitamin A carotenoid, omega-3 fatty acids, and non proform Vitamin A carotenoids including lutein and/or zeaxanthin. The essential ingredients are provided in a form suitable of oral ingestion or other forms of administration in one or more doses per day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.